The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The United States intravenous solution market is currently witnessing moderate growth. Intravenous (IV) solutions are a complete mix of essential nutrients that help to replenish fluid loss, treat electrolyte imbalance and maintain fluid balance in IV therapy. These solutions provide nutrients to patients who have diabetes, cancer, and other such diseases. IV solutions contain water with electrolytes, sugar, or medications added in concentrations according to the patient’s medical condition, age and body size. Furthermore, the manufacturers are coming up with new and innovative products, such as premixed solutions that provide better convenience and reduce packaging wastage.
The United States IV solution market is primarily driven by the growing prevalence of lifestyle diseases and the increasing geriatric population. Besides this, a well-developed healthcare industry, coupled with high per capita healthcare expenditure and the ready availability of IV solutions are also propelling the growth of the market across the country. The rising prevalence of gastrointestinal and neurological diseases is also acting as another major growth-inducing factor. Moreover, IV solutions are available in portable packages, thus making it easy for the patients to use drips from within the comfort of their homes. This, in turn, is creating a positive outlook for the market in the United States. As a result of these factors, IMARC Group expects the market to continue its moderate growth during the forecast period (2021-2026).
IMARC Group provides an analysis of the key trends in each sub-segment of the United States intravenous solution market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, type and nutrients.
Breakup by Type:
Breakup by Nutrients:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at